{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:12:17Z","timestamp":1789992737358,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","award":["K01OD034451"],"award-info":[{"award-number":["K01OD034451"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","award":["T35OD033655"],"award-info":[{"award-number":["T35OD033655"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajpath.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:17:28Z","timestamp":1783034248000},"page":"2223-2236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MYC Is Functionally Required in Both Normal and Neoplastic Meibomian Glands"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0776-4849","authenticated-orcid":false,"given":"Isabella","family":"Boyack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn","family":"Berlied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-1883","authenticated-orcid":false,"given":"Cornelia","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.05.013_bib1","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2026.05.013_bib2","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ophtha.2004.07.031","article-title":"Sebaceous carcinoma of the eyelids: personal experience with 60 cases","volume":"111","author":"Shields","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajpath.2026.05.013_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2004.12.008","article-title":"Sebaceous carcinoma of the ocular region: a review","volume":"50","author":"Shields","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/ICU.0000000000000505","article-title":"Current review of sebaceous cell carcinoma","volume":"29","author":"Orr","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.sjopt.2013.05.002","article-title":"Periocular sebaceous gland carcinoma: a comprehensive review","volume":"27","author":"Mulay","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib6","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1016\/S1470-2045(19)30673-4","article-title":"Sebaceous carcinoma: evidence-based clinical practice guidelines","volume":"20","author":"Owen","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1158\/1078-0432.CCR-18-1688","article-title":"Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through nonoverlapping molecular-genetic alterations","volume":"15","author":"Tetzlaff","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2026.05.013_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.4759","article-title":"Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma","volume":"240","author":"Tetzlaff","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41379-020-0454-y","article-title":"Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis","volume":"33","author":"Xu","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib10","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.3390\/ijms22168454","article-title":"NGS analysis confirms common TP53 and RB1 mutations, and suggests MYC amplification in ocular adnexal sebaceous carcinomas","volume":"22","author":"Peterson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.05.013_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s42003-023-04632-5","article-title":"Primary cilia control cellular patterning of Meibomian glands during morphogenesis but not lipid composition","volume":"6","author":"Portal","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diff.2023.04.005","article-title":"Meibomian gland development: where, when and how?","volume":"132","author":"Verma","year":"2023","journal-title":"Differentiation"},{"key":"10.1016\/j.ajpath.2026.05.013_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.63.2.3","article-title":"The c-Myc oncogene maintains corneal epithelial architecture at homeostasis, modulates p63 expression, and enhances proliferation during tissue repair","volume":"63","author":"Portal","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2026.05.013_bib14","series-title":"Novel gene biomarkers associated with Meibomian gland dysfunction [doctoral dissertation]","author":"Lee","year":"2016"},{"key":"10.1016\/j.ajpath.2026.05.013_bib15","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1002\/jcb.28742","article-title":"Prediction of potential drugs and targets based on meibomian gland dysfunction module classification to guide individualized treatment","volume":"120","author":"Ni","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ajpath.2026.05.013_bib16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10792-017-0577-4","article-title":"Manifestation of meibomian gland dysfunction in patients with Sj\u00f6gren's syndrome, non-Sj\u00f6gren's dry eye, and non-dry eye controls","volume":"38","author":"Kang","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib17","first-page":"921","article-title":"Prevalence of Meibomian gland dysfunction in Sjogren's syndrome patients [abstract]","volume":"59","author":"Srinivasan","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2026.05.013_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102358","article-title":"LncRNA PVT1 links Myc to glycolytic metabolism upon CD4+ T cell activation and Sj\u00f6gren's syndrome-like autoimmune response","volume":"107","author":"Fu","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ajpath.2026.05.013_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12917-020-02451-y","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"16","author":"Percie du Sert","year":"2020","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.ajpath.2026.05.013_bib20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0960-9822(01)00154-3","article-title":"c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny","volume":"11","author":"Arnold","year":"2001","journal-title":"Curr Biol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/cells14100709","article-title":"A potential role for c-MYC in the regulation of meibocyte cell stress","volume":"14","author":"Boyack","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2026.05.013_bib22","article-title":"Establishment and characterization of three human ocular adnexal sebaceous carcinoma cell lines","volume":"25","author":"Lee","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.05.013_bib23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.18632\/oncotarget.1108","article-title":"Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5","volume":"4","author":"Wang","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2026.05.013_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/jpet.110.170555","article-title":"In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc\/Max dimerization","volume":"335","author":"Clausen","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2026.05.013_bib25","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1073\/pnas.97.7.3118","article-title":"Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis","volume":"97","author":"Salghetti","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2026.05.013_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccell.2019.10.001","article-title":"Small-molecule MYC inhibitors suppress tumor growth and enhance immunotherapy","volume":"36","author":"Han","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2026.05.013_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28107-4","article-title":"A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation","volume":"8","author":"Castell","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2026.05.013_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10637-020-01018-w","article-title":"The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells","volume":"39","author":"AlSultan","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ajpath.2026.05.013_bib29","first-page":"2573","article-title":"Clonogenic assay: adherent cells","author":"Rafehi","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2026.05.013_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/cancers18020349","article-title":"Fatty acid synthase as a potential metabolic vulnerability in ocular adnexal sebaceous carcinoma","volume":"18","author":"Berlied","year":"2026","journal-title":"Cancers"},{"key":"10.1016\/j.ajpath.2026.05.013_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101898","article-title":"Functional inhibition of c-Myc using novel inhibitors identified through \"hot spot\" targeting","volume":"298","author":"Singh","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2026.05.013_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","article-title":"Myc and cell cycle control","volume":"1849","author":"Bretones","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2026.05.013_bib33","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1128\/MCB.24.10.4294-4308.2004","article-title":"Visualization of Myc\/Max\/Mad family dimers and the competition for dimerization in living cells","volume":"24","author":"Grinberg","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib34","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1038\/sj.onc.1203040","article-title":"Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis","volume":"18","author":"Waikel","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2026.05.013_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc2328","article-title":"MYC in mammalian epidermis: how can an oncogene stimulate differentiation?","volume":"8","author":"Watt","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2026.05.013_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13287-019-1187-z","article-title":"Impact of c-MYC expression on proliferation, differentiation, and risk of neoplastic transformation of human mesenchymal stromal cells","volume":"10","author":"Melnik","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ajpath.2026.05.013_bib37","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1101\/gad.11.21.2869","article-title":"c-Myc promotes differentiation of human epidermal stem cells","volume":"11","author":"Gandarillas","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2026.05.013_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene\u2014the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib39","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/sj.onc.1202746","article-title":"MYC oncogenes and human neoplastic disease","volume":"18","author":"Nesbit","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2026.05.013_bib40","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1158\/0008-5472.CAN-10-3776","article-title":"MYC and metastasis","volume":"71","author":"Wolfer","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2026.05.013_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2026.05.013_bib42","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014241","article-title":"MYC activation is a hallmark of cancer initiation and maintenance","volume":"4","author":"Gabay","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ajpath.2026.05.013_bib43","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014407","article-title":"MYC and the control of apoptosis","volume":"4","author":"McMahon","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ajpath.2026.05.013_bib44","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1038\/s41467-022-32368-z","article-title":"MYC sensitises cells to apoptosis by driving energetic demand","volume":"13","author":"Edwards-Hicks","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2026.05.013_bib45","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/cancers11081144","article-title":"Cancer metabolism and the evasion of apoptotic cell death","volume":"11","author":"Sharma","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2026.05.013_bib46","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/MCB.22.17.6158-6169.2002","article-title":"c-Myc functionally cooperates with Bax to induce apoptosis","volume":"22","author":"Juin","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib47","doi-asserted-by":"crossref","first-page":"31014","DOI":"10.18632\/oncotarget.8826","article-title":"Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation","volume":"7","author":"Fiorentino","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2026.05.013_bib48","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.molcel.2017.07.028","article-title":"Global inhibition with specific activation: how p53 and MYC redistribute the transcriptome in the DNA double-strand break response","volume":"67","author":"Porter","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2026.05.013_bib49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(02)00738-9","article-title":"Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression","volume":"109","author":"Pelengaris","year":"2002","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.ajpath.2026.05.013_bib60","doi-asserted-by":"crossref","first-page":"10258","DOI":"10.1073\/pnas.1222404110","article-title":"MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells","volume":"110","author":"Zirath","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2026.05.013_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12032-020-01436-z","article-title":"Association between the CEBPA and c-MYC genes expression levels and acute myeloid leukemia pathogenesis and development","volume":"37","author":"Krygier","year":"2020","journal-title":"Med Oncol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib51","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcb.30437","article-title":"PPAR\u03b3 agonist inhibits c-Myc-mediated colorectal cancer tumor immune escape","volume":"124","author":"Xu","year":"2023","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ajpath.2026.05.013_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/excr.1999.4736","article-title":"Inhibition of the terminal stages of adipocyte differentiation by cMyc","volume":"254","author":"Heath","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ajpath.2026.05.013_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1268275","article-title":"MYC function and regulation in physiological perspective","volume":"11","author":"Jha","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ajpath.2026.05.013_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh3635","article-title":"A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression","volume":"8","author":"Holmes","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajpath.2026.05.013_bib55","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1101\/gad.907901","article-title":"Regulation of cyclin D2 gene expression by the Myc\/Max\/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter","volume":"15","author":"Bouchard","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2026.05.013_bib56","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","article-title":"Low molecular weight inhibitors of Myc-Max interaction and function","volume":"22","author":"Yin","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2026.05.013_bib57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41388-020-01553-z","article-title":"A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer","volume":"40","author":"Singh","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2026.05.013_bib58","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.exer.2009.08.013","article-title":"Age-related changes in the meibomian gland","volume":"89","author":"Nien","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajpath.2026.05.013_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/iovs.64.15.16","article-title":"Establishment and characterization of a TP53-mutated eyelid sebaceous carcinoma cell line","volume":"64","author":"Gu","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026001914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026001914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:41:17Z","timestamp":1789990877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026001914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0002944026001914"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.05.013","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYC Is Functionally Required in Both Normal and Neoplastic Meibomian Glands","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}